- Epidemic of Fear: How the Trouble-Ridden Debut of a Breakthrough Vaccine Sparked a PanicFrench pharma giant Sanofi believed its dengue fever shot would defeat an insidious illness. Then came the vaccine’s rollout in the Philippines—and a scare that could have dire consequences.
- Novartis' $9.7 Billion Deal Sets off Heart Drug WarsNovartis is buying cholesterol drug maker The Medicines Company at a sharp premium—and it's setting off speculation about future heart drug deals.
- Novartis Bets Big on Cholesterol Drug With $9.7 Billion AcquisitionIt's the latest in a string of recent acquisitions for Novartis chief executive officer Vas Narasimhan.
- Which Medicines Have Transformed Drug Development in the Past Decade?This is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here. Happy Friday, readers! I have a selfish request of all of you this evening. If you have any thoughts about which drugs, medicines, therapies, procedures, etc have served […]
- This Doctor Wants to Use Blockchain to Cut Cancer Drug Development Costs in HalfRenowned UCSF oncologist Laura Esserman wants to use Salesforce Blockchain to slash the cost of breast cancer drug development.
- No Safety Switch: How Lax Oversight of Electronic Health Records Puts Patients at RiskSpecial interests and congressional inaction doomed efforts to regulate electronic medical records, putting patients at risk.
- OxyContin’s Maker Is Still Flourishing In ChinaThis is the web version of Brainstorm Health Daily, Fortune’s daily newsletter on the top health care news. To get it delivered daily to your in-box, sign up here. Good afternoon, readers. The opioid addiction crisis that’s killed or otherwise sickened millions of Americans has galvanized significant backlash. Alleged perpetrators range from drug developers to drug distributors […]
Skip to Content